<DOC>
	<DOC>NCT01900886</DOC>
	<brief_summary>Primary objective: Evaluate the prevalence of personality disorders in patients starting treatment for hepatitis C in the prison and determine their influence on the evolution of the disease.</brief_summary>
	<brief_title>Epidemiological Study to Evaluate Personality Disorders in Prison Populations in Treatment for Hepatitis C</brief_title>
	<detailed_description>Secondary objectives: - Describe the management of patients with personality disorders on treatment for hepatitis C in the prison. - Describe the characteristics of patients who discontinue the treatment and the reasons for stratifying by the presence of personality disorders.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Patients 18 years of age. Patients with expected prison stay beyond the duration of followup period of the study. Patients with chronic HCV infection and detectable viral load to initiate treatment with standard therapy. Patients their written informed consent to participate in the study. Patients previously treated with Interferon (IFN) and Ribavirin (RBV). Patients can not read or understand a written questionnaire at the discretion of the investigator.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>prison, disorder, hepatitis c</keyword>
</DOC>